
Novartis: Research and Development grows 4.8%
Pharmaceutical company Novartis AG invested $9.996 billion in Research and Development in 2022, an increase of 4.8% year-on-year. In April 2022, the company announced the
Pharmaceutical company Novartis AG invested $9.996 billion in Research and Development in 2022, an increase of 4.8% year-on-year. In April 2022, the company announced the
The IMF has proposed a plan, jointly supported by the World Health Organization (WHO), the World Bank and the World Trade Organization (WTO), to vaccinate against Covid-19 at least 40% of the population in all countries. countries by the end of 2021 and 70% by mid-2022, in addition to ensuring adequate diagnosis and treatment.
Pharmaceutical company Novartis AG invested $9.996 billion in Research and Development in 2022, an increase of 4.8% year-on-year. In April 2022, the company announced the
The IMF has proposed a plan, jointly supported by the World Health Organization (WHO), the World Bank and the World Trade Organization (WTO), to vaccinate against Covid-19 at least 40% of the population in all countries. countries by the end of 2021 and 70% by mid-2022, in addition to ensuring adequate diagnosis and treatment.
Redacción: 7224059128
info@opportimes.com